Who
Susan D. DeVore
Director
Company insider
Files Form 4 as: Director, Unum Group; Director, Solventum; Director, Elevance Health; Chief Executive Officer, Premier.
In numbers
- Trades disclosed
- 66
- Buys
- 2
- Sells
- 4
- Bought
- $780K
- Sold
- $4.8M
- Companies
- 4
- Companies where not an officer
- 3
- First trade
- 25 Sep 2013
- Last trade
- 26 May 2026
- Last filed
- 28 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 May 2026filed 28 May 2026 | UNM Unum GroupInsurance | SEC FORM 4 Code A | —2,191 at $0.00 | filing |
| 26 May 2026filed 28 May 2026 | UNM Unum GroupInsurance | SEC FORM 4 Code A | —2,191 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,300 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,300 at $0.00 | filing |
| 13 May 2026filed 15 May 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code A | —563 at $0.00 | filing |
| 13 May 2026filed 15 May 2026 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code A | —563 at $0.00 | filing |
| 30 Apr 2026filed 1 May 2026 | SOLV SolventumMedical Devices | SEC FORM 4 Code M | —3,403 at $0.00 | filing |
| 30 Apr 2026filed 1 May 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,403 at $0.00 | filing |
| 30 Apr 2026filed 1 May 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,403 at $0.00 | filing |
| 30 Apr 2026filed 1 May 2026 | SOLV SolventumMedical Devices | SEC FORM 4 Code M | —3,403 at $0.00 | filing |
| 27 Mar 2026filed 30 Mar 2026 | SOLV SolventumMedical Devices | SEC FORM 4 Code M | —1,980 at $0.00 | filing |
| 27 Mar 2026filed 30 Mar 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,980 at $0.00 | filing |
| 27 Mar 2026filed 30 Mar 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,980 at $0.00 | filing |
| 27 Mar 2026filed 30 Mar 2026 | SOLV SolventumMedical Devices | SEC FORM 4 Code M | —1,980 at $0.00 | filing |
| 19 Aug 2025filed 21 Aug 2025 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Bought | $375K1,200 at $312.15 | filing |
| 22 May 2025filed 23 May 2025 | UNM Unum GroupInsurance | SEC FORM 4 Code A | —2,198 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code A | —601 at $0.00 | filing |
| 13 May 2025filed 15 May 2025 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,564 at $0.00 | filing |
| 13 May 2025filed 15 May 2025 | SOLV SolventumMedical Devices | SEC FORM 4 Code M | —3,564 at $0.00 | filing |
| 30 Apr 2025filed 2 May 2025 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,403 at $0.00 | filing |
News
Elevance Health, Inc. (NYSE:ELV) to Issue Quarterly Dividend of $1.72ELV · themarketsdaily.com · 21 Oct 2026Elevance Health Raises 2026 Outlook As Third-Quarter Profit Tops Prior YearELV · rttnews.com · 21 Oct 2026Elevance Health reaches $425.27, completing a full-year round tripELV · 247wallst.com · 14 Oct 2026
0 headlines in the last 90 days name Susan D. DeVore; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.